REVIVA

What this means for you

Registered since 23 Aug 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 23 Aug 2021).

Record

Serial number

77166973

Registration number

4016184

Mark type

Stylized text

Filed

26 Apr 2007

Published for opposition

08 Apr 2008

Registered

23 Aug 2011

Next maintenance due

23 Aug 2021

Attorney of record

Connie L. Ellerbach

Goods and services

• Class 042 — Scientific and technological services: Pharmaceutical drug research and development, including conducting clinical trials and consulting services related thereto; pharmaceutical research and development services, namely, designing, conducting and managing clinical trials and reporting the results of same; providing analysis and design services in the field of drug development and conducting clinical trials of newly developed drugs

Owner

• Reviva Pharmaceuticals, Inc., Cupertino, CA, US
• Reviva Pharmaceuticals, Inc., San Jose, CA, US
• Reviva Pharmaceuticals, Inc., San Jose, CA, US

Prosecution history

• 24 Nov 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
• 24 Nov 2021 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
• 24 Nov 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
• 24 Nov 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 01 Jul 2021 — TEAS SECTION 8 & 9 RECEIVED
• 23 Aug 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
• 27 Sept 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
• 27 Sept 2017 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
• 26 Sept 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 22 Aug 2017 — TEAS SECTION 8 & 15 RECEIVED
• 23 Aug 2011 — REGISTERED-PRINCIPAL REGISTER
• 20 Jul 2011 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 19 Jul 2011 — LAW OFFICE REGISTRATION REVIEW COMPLETED
• 18 Jul 2011 — ASSIGNED TO LIE
• 17 Jul 2011 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED